Expression and tissue distribution of the mRNAs encoding the human thromboxane A2 receptor (TP) α and β isoforms

Biochimica et Biophysica Acta - General Subjects

Volumn 1425, Issue 3, 1998, Pages 543-559

  Miggin, Sinead M ^a   Kinsella, B Therese ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Gene expression; Isoform; Receptor; Thromboxane A2; Thromboxane A2 receptor( ); Thromboxane A2 receptor( )

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; THROMBOXANE A2;

ARTICLE; BRAIN TISSUE; CELL LINE; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; HEPATOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE; TROPHOBLAST;

BLOTTING, SOUTHERN; BRAIN; CELL LINE; ENDOTHELIUM, VASCULAR; HUMANS; HYDRAZINES; INTESTINE, SMALL; PROTEIN ISOFORMS; RECEPTORS, THROMBOXANE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOXANE A2; THYMUS GLAND; TROPHOBLASTS; TUMOR CELLS, CULTURED;

EID: 0031762633     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(98)00109-3     Document Type: Article

References (70)

1. M. Hamberg, J. Svensson, B. Samuelsson, Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides, Proc. Natl. Acad. Sci. U.S.A. 72 (1975) 2994-2998.
2. 2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems, J. Biol. Chem. 265 (1990) 6836-6844.
3. 2 in vascular smooth muscle cells, Biochem. Pharmacol. 40 (1990) 2535-2542.
4. 2 receptors in streptozotocin-induced diabetes: effects of insulin therapy in the rat, Prostaglandins 45 (1993) 427-438.
5. G.W. Dorn II, M.W. Becker, M.G. Davis, Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle, J. Biol. Chem. 267 (1992) 24897-24905.
6. R.A. Coleman, R.M. Eglen, R.L. Jones, S. Narumiya, T. Shimizu, W.L. Smith, S.E. Dahlen, J.M. Drazen, P.J. Gardiner, W.T. Jackson, T.R. Jones, R.D. Krell, S. Nicosia, Prostanoid and leukotriene receptors : a progress report from the IUPHAR working parties on classification and nomenclature, Adv. Prostaglandin Thromboxane Leukot. Res. 23 (1995) 283-285.
7. 2, Science 193 (1976) 1135-1137.
8. 2, Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 1706-1710.
9. G. Rasmanis, O. Vesterqvist, K. Green, P. Henriksson, Implications of the prognostic importance of exercise-induced thromboxane formation in survivors of an acute myocardial infarction, Prostaglandins 49 (1995) 247-253.
10. 2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits, Atherosclerosis 31 (1978) 385-394.
11. 2 synthesis in pregnancy-induced hypertension, Lancet 335 (1990) 751-754.
12. 2 synthesis by ureteral obstruction in the rabbit kidney, Nature 267 (1977) 259-260.
13. R.F. Spurney, R.J. Bernstein, P. Ruiz, D.S. Pisetsky, T.M. Coffman, Physiologic role for enhanced renal thromboxane production in murine lupus nephritis, Prostaglandins 42 (1991) 15-28.
14. 2 in normal and dysmenorrheic women and their temporal relationship to dysmenorrhoea, Prostaglandins 29 (1985) 273-289.
15. A. Aitokollio-Tallberg, Prostacyclin and thromboxane synthesis by endometrial cancer and leiomyomas, Prostaglandins 39 (1990) 259-266.
16. 2 in bronchial hyperresponsiveness of asthma, Pulm. Pharmacol. 8 (1995) 251-257.
17. 2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis, J. Exp. Med. 178 (1993) 1825-1830.
18. S. Kuwamoto, H. Inoue, Y. Tone, Y. Izumi, T. Tanabe, Inverse gene expression of prostacyclin and thromboxane synthases in resident and activated peritoneal macrophages, FEBS Lett. 409 (1997) 242-246.
19. 2 receptor agonist, J. Pharmacol. Exp. Ther. 251 (1989) 557-562.
20. M.L. Ogletree, G.T. Allen, Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles, J. Pharmacol. Exp. Ther. 260 (1992) 789-794.
21. 2 receptors in platelets and blood vessels: evidence for different receptors, J. Pharmacol. Exp. Ther. 233 (1985) 418-424.
22. 2 receptor ligand (S-145) in platelets and vascular and airway smooth muscle, J. Pharmacol. Exp. Ther. 262 (1992) 784-791.
23. 2 receptor, Nature 349 (1991) 617-620.
24. 2 receptor: cDNA cloning, expression and northern blot analysis, Biochem. Biophys. Res. Commun. 184 (1992) 1197-1203.
25. 2 receptor from rat astrocytes, Biochim. Biophys. Acta 1265 (1995) 220-223.
26. T. Abe, K. Takeuchi, N. Takahashi, E. Tsutsumi, Y. Taniyama, K. Abe, Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization, J. Clin. Invest. 96 (1995) 657-664.
27. 2 receptor: molecular cloning, expression, and functional characterization, Naunyn Schmiedebergs Arch. Pharmacol. 357 (1998) 10-16.
28. 2 receptor gene, J. Biol. Chem. 268 (1993) 25253-25259.
29. 2 receptor, Adv. Prostaglandin Thromboxane Leukot. Res. 23 (1995) 247-249.
30. 2 receptor, J. Biol. Chem. 269 (1994) 19256-19261. (published erratum, J. Biol. Chem. 270 (1995) 7011)
31. 2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation, J. Clin. Invest. 97 (1996) 949-956.
32. 2 receptor, J. Biol. Chem. 269 (1994) 29914-29919.
33. A. Habib, R. Vezza, C. Creminon, J. Maclouf, G.A. FitzGerald, Rapid, agonist-dependent phosphorylation in vivo of human thromboxane receptor isoforms. Minimal involvement of protein kinase C, J. Biol. Chem. 272 (1997) 7191-7200.
34. 2α, J. Pharmacol. Exp. Ther. 281 (1997) 957-964.
35. B.T. Kinsella, D.J. O'Mahony, J.A. Lawson, D. Pratico, G.A. Fitzgerald, Cellular activation of thromboxane receptors, Ann. N.Y. Acad. Sci. 714 (1994) 270-278.
36. T. Namba, H. Oida, Y. Sugimoto, A. Kakizuka, M. Negishi, A. Ichikawa, S. Narumiya, cDNA cloning of a mouse prostacyclin receptor. Multiple signaling pathways and expression in thymic medulla, J. Biol. Chem. 269 (1994) 9986-9992.
37. 2 receptor α and β isoforms, J. Pharmacol. Exp. Ther. 286 (1998) 1026-1036.
38. N. Perez-Reyes, C.L. Halbert, P.P. Smith, E.P. Benditt, J.K. McDougall, Immortalization of primary human smooth muscle cells, Proc. Natl. Acad. Sci U.S.A. 89 (1992) 1224-1228.
39. J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
40. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem. 72 (1976) 248-254.
41. M. Hirata, A. Kakizuka, M. Aizawa, F. Ushikubi, S. Narumiya, Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene, Proc. Natl. Acad. Sci U.S.A. 91 (1994) 11192-11196.
42. 1 subtype, J. Biol. Chem. 268 (1993) 26767-26772.
43. J.W. Regan, T.J. Bailey, D.J. Pepperl, K.L. Pierce, A.M. Bogardus, J.E. Donello, C.E. Fairbairn, K.M. Kedzie, D. Woodward, D.W. Gil, Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically denned EP2 subtype, Mol. Pharmacol. 46 (1994) 213-220.
44. 3 subtype, J. Biol. Chem. 267 (1992) 6463-6466.
45. 3 subtype, J. Biol. Chem. 268 (1993) 9517-9521.
46. 4 subtype, FEBS Lett. 364 (1995) 339-341.
47. 2 subtype, J. Biol. Chem. 268 (1993) 7759-7762.
48. M. Abramovitz, Y. Boie, T. Nguyen, T.H. Rushmore, M.A Bayne, K.M. Metters, D.M. Slipetz, R. Grygorczyk, Cloning and expression of a cDNA for the human prostanoid FP receptor, J. Biol. Chem. 269 (1994) 2632-2636.
49. T. Namba, H. Oida, Y. Sugimoto, A. Kakizuka, M. Negishi, A. Ichikawa, S. Narumiya, cDNA cloning of a mouse prostacyclin receptor, J. Biol. Chem. 269 (1994) 9986-9992.
50. 3 determines G-protein specificity, Nature 365 (1993) 166-170.
51. 3 receptors : evidence of three variants with differing carboxyl termini, Br. J. Pharmacol. 112 (1994) 377-385.
52. K.L. Pierce, T.J. Bailey, P.B. Hoyer, D.W. Gil, D.F. Woodward, J.W. Regan, Cloning of a carboxyl-terminal isoform of the prostanoid FP receptor, J. Biol. Chem. 272 (1997) 883-887.
53. i proteins, J. Biol. Chem. 268 (1993) 2712-2718.
54. 3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase, Eur. J. Biochem. 217 (1993) 313-318.
55. 2 receptor transduce both intracellular calcium and cAMP signals, Biochemistry 33 (1994) 14496-14502.
56. M. Negishi, Y. Sugimoto, A. Irie, S. Narumiya, A. Ichikawa, Two isoforms of prostaglandin E receptor EP3 subtype. Different COOH-terminal domains determine sensitivity to agonist-induced desensitization, J. Biol. Chem. 268 (1993) 9517-9521.
57. 2 receptor interaction, J. Pharmacol. Exp. Ther. 228 (1984) 240-244.
58. 2 in mitogenesis of vascular smooth muscle cells, Agents Actions Suppl. 48 (1997) 42-62.
59. 2 have potent and differentiated actions on uterine contractility, Prostaglandins 21 (1981) 277-285.
60. 2 receptor gene in human uterus, Biol. Reprod. 47 (1992) 105-117.
61. Y.W. Loke, A. Whyte (Eds.), Biology of Trophoblast, Elsevier, New York, 1983.
62. B. Wetzka, D.S. Charnock-Jones, B. Viville, J.C. Cooper, R. Nusing, H.P. Zahradnik, S.K. Smith, Expression of prostacyclin and thromboxane synthases in placenta and placental bed after pre-eclamptic pregnancies, Placenta 17 (1996) 573-581.
63. M.A. Cruz, V. Gallardo, P. Miguel, G. Carrasco, C. Gonzalez, Serotonin-induced vasoconstriction is mediated by thromboxane release and action in the human fetal-placental circulation, Placenta 18 (1997) 197-204.
64. 2 agonist modulation of excitatory synaptic transmission in the rat hippocampal slice, Br. J. Pharmacol. 118 (1996) 2220-2227.
65. 2 receptor antagonist, S-1452, on post-ischaemic brain injury in rats, Stroke 24 (1993) 2059-2065.
66. 2 receptors by immunoaffinity chromatography employing anti-peptide and anti-receptor antibodies, J. Biol. Chem. 269 (1994) 6109-6116.
67. 2 receptor from rat astrocytes, Biochim. Biophys. Acta 1265 (1995) 220-223.
68. 2 receptors, J. Biol. Chem. 273 (1998) 475-483.
69. 2 receptors in experimental alcoholic liver disease, J. Pharmacol. Exp. Ther. 282 (1997) 1037-1043.
70. 2 receptor antagonist in an animal model of inflammatory bowel disease, Digestion 58 (1997) 476-478.